HOME Top Market Reports HIV Diagnosis Market by Test Type (Antibody (ELISA, Rapid, Western Blot), Viral Load, CD4 Count, Early Infant, Viral Identification, Product (Assay, Kit, Reagent, Instrument, Software, Services), End User (Hospitals) - Global Forecast to 2021

HIV Diagnosis Market by Test Type (Antibody (ELISA, Rapid, Western Blot), Viral Load, CD4 Count, Early Infant, Viral Identification, Product (Assay, Kit, Reagent, Instrument, Software, Services), End User (Hospitals) - Global Forecast to 2021

By: marketsandmarkets.com
Publishing Date: March 2017
Report Code: MD 5067

 

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


The HIV diagnosis market is projected to reach USD 3.88 Billion by 2021 from USD 2.35 Billion in 2016, at a CAGR of 10.5% from 2016 to 2021.

On the basis of product, the market is segmented into consumables (assays, kits, reagents, and other consumables), instruments, and software and services. In 2016, the consumables segment is expected to account for the largest share of the market. The frequent and repetitive purchase of consumables by laboratories and hospitals, growing prevalence of HIV/AIDS, and increasing initiatives from governments to fight HIV/AIDS are some of the major factors driving the consumables market.

On the basis of test type, the market is segmented into antibody tests, viral load tests, CD4 count tests, tests for early infant diagnosis, and tests for viral identification. The antibody tests segment is further divided into HIV-1 screening tests, HIV-1 confirmatory tests, and HIV-2 and group O diagnostic tests. The antibody tests segment is expected to account for the largest share of the market in 2016. This large share can be attributed to the increasing technological advancements in HIV diagnosis, growing awareness about HIV, and rising blood donations.

On the basis of end user, the HIV diagnosis market is divided into diagnostic laboratories, hospitals, blood banks, home care settings, and others (gene banks, cell banks, biotechnology and pharmaceutical companies, and academic research institutes). The diagnostic laboratories segment is expected to account for the largest share of market in 2016. This large share is mainly due to high investment and technological advancements of diagnostics laboratories. It is also driven by increasing awareness of HIV/AIDS.

Geographically, the market is dominated by North America. Growth in the North American segment is primarily driven by the high incidence and prevalence of HIV/AIDS, increasing awareness about HIV/AIDS, and growing government initiatives and increasing blood donations.

The major players in the market are Siemens AG (Germany), Roche Diagnostics (Switzerland), Abbott Laboratories (U.S), Danaher Corporation (U.S.), Thermo-Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Becton, Dickinson and Company (U.S.), Hologic, Inc. (U.S.), Alere Inc. (U.S.), and Bio-Rad Laboratories (U.S.).

Target Audience for this Report:

  • Manufacturers of HIV Diagnosis Products
  • Vendors and Distributors of Powered Surgical Instruments
  • Hospitals
  • Research Institutes Related to HIV/AIDS Studies
  • Venture Capitalists and Investors

Value Addition for the Buyer:

This report provides insights into the global HIV diagnosis market. It provides valuable information on the product, test type, and region in the market. The geographic analysis for these segments is also presented in this report. Leading players in the market are profiled to study their product offerings and understand strategies undertaken by them to be competitive in this market.

The above-mentioned information would help the buyer understand market dynamics. In addition, the forecasts provided in the report will enable firms to understand the trends in this market and better position themselves to capitalize on the growth opportunities.

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report:

This report categorizes the HIV diagnosis market into the following segments:

HIV Diagnosis Market, by Product

  • Consumables
  • Assay, Kits, and Reagents
  • Other Consumables
  • Instruments
  • Software and Services

HIV Diagnosis Market, by Test Type

  • Antibody Tests
    • HIV-1 Screening Tests
      • ELISA
      • Rapid Tests
      • Home Access Dried Blood Spot
    • HIV-1 Confirmatory Tests
      • Western Blot Tests
      • Indirect Immune Fluorescent Antibody Assays (IFA)
      • Line Immunoassays (LIA)
      • Radio-Immunoprecipitation Assays (RIPA)
    • HIV-2 & Group O Diagnostic Tests
  • Viral Load Tests
  • CD4 Tests
  • Tests for Early Infant Diagnosis
  • Tests for Viral Identification

HIV Diagnosis Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
  • Asia
    • China
    • Japan
    • India
    • RoA
  • Rest of the World (RoW)

Customization Options:

  • Company Information: Detailed company profiles of five or more market players
  • Opportunities Assessment: A detailed report underlining the various growth opportunities presented in the market

Table of Contents

1 Introduction (Page No. - 14)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 17)
    2.1 Secondary Data
           2.1.1 Key Data From Secondary Sources
    2.2 Primary Data
           2.2.1 Key Data From Primary Sources
    2.3 Market Size Estimation
           2.3.1 Bottom-Up Approach
           2.3.2 Top-Down Approach
    2.4 Market Breakdown and Data Triangulation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 25)
    3.1 Introduction
    3.2 Conclusion

4 Premium Insights (Page No. - 28)
    4.1 HIV Diagnosis: Market Overview
    4.2 Geographic Analysis: HIV Diagnosis Market, By Test Type (2016)
    4.3 Geographic Snapshot of the Market
    4.4 Life Cycle Analysis, By Region

5 Market Overview (Page No. - 32)
    5.1 Introduction
           5.1.1 Drivers
                    5.1.1.1 Growing Worldwide Prevalence of HIV/Aids
                    5.1.1.2 Increasing Number of Blood Transfusions and Blood Donations
                    5.1.1.3 Benefits Offered By Point-Of-Care Instruments & Kits
                    5.1.1.4 Increasing Government Initiatives
           5.1.2 Restraints
                    5.1.2.1 High Cost of Nat
                    5.1.2.2 Lack of Mandates for Nat in Developing Countries
           5.1.3 Opportunity
                    5.1.3.1 Emerging Economies Offer Lucrative Growth Opportunities for HIV Diagnosis
           5.1.4 Trend
                    5.1.4.1 Increase in Use of Home Access Kits and Instruments

6 HIV Diagnosis Market, By Product (Page No. - 39)
    6.1 Introduction
    6.2 Consumables
           6.2.1 Assays and Kits & Reagents
           6.2.2 Other Consumables
    6.3 Instruments
    6.4 Software & Services

7 HIV Diagnosis Market, By Test Type (Page No. - 47)
    7.1 Introduction
    7.2 Antibody Tests
           7.2.1 HIV-1 Screening Tests
                    7.2.1.1 Elisa
                    7.2.1.2 Rapid Tests
                    7.2.1.3 Home Access Dried Blood Spots
           7.2.2 HIV-1 Antibody Confirmatory Tests
                    7.2.2.1 Western Blot Tests
                    7.2.2.2 Indirect Immunofluorescence Assays (IFA)
                    7.2.2.3 Line Immunoassays
                    7.2.2.4 Radio-Immunoprecipitation Assays
           7.2.3 HIV-2 & Group O Diagnostic Tests
    7.3 Viral Load Tests
    7.4 CD4 Tests
    7.5 Tests for Early Infant Diagnosis
    7.6 Tests for Viral Identification

8 HIV Diagnosis Market, By End User (Page No. - 64)
    8.1 Introduction
    8.2 Diagnostic Laboratories
    8.3 Hospitals
    8.4 Blood Banks
    8.5 Home Care Settings
    8.6 Other End Users

9 HIV Diagnosis Market, By Region (Page No. - 71)
    9.1 Introduction
    9.2 North America
           9.2.1 U.S.
           9.2.2 Canada
    9.3 Europe
    9.4 Asia
           9.4.1 China
           9.4.2 Japan
           9.4.3 India
           9.4.4 Rest of Asia (RoA)
    9.5 Rest of the World (RoW)

10 Competitive Landscape (Page No. - 98)
     10.1 Introduction
     10.2 Strategic Overview
     10.3 Market Share Analysis
     10.4 Competitive Situation and Trends
             10.4.1 Product Launches
             10.4.2 Agreements, Partnerships & Collaborations
             10.4.3 Expansions
             10.4.4 Other Developments

11 Company Profiles (Page No. - 104)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
     11.1 Introduction
     11.2 Siemens Healthineers (A Division of Siemens AG)
     11.3 Roche Diagnostics (Division of Hoffman La Roche Ltd.)
     11.4 Abbott Laboratories
     11.5 Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
     11.6 Thermo-Fisher Scientific Inc.
     11.7 Merck KGaA
     11.8 Becton, Dickinson & Company
     11.9 Hologic Inc.
     11.10 Alere Inc.
     11.11 Bio-Rad Laboratories

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 129)
     12.1 Insights of Industry Experts
     12.2 Discussion Guide
     12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.4 Introducing RT: Real-Time Market Intelligence
     12.5 Available Customizations
     12.6 Related Reports
     12.7 Author Details


List of Tables (72 Tables)

Table 1 Global HIV Prevalence, 2015
Table 2 Global HIV Diagnosis Market Size, By Product, 2014–2021 (USD Million)
Table 3 Global HIV Diagnosis Market Size for Consumables, By Type, 2014–2021 (USD Million)
Table 4 Global HIV Diagnosis Market Size for Consumables, By Region, 2014–2021 (USD Million)
Table 5 Global HIV Diagnosis Market Size for Assays and Kits & Reagents, By Region, 2014–2021 (USD Million)
Table 6 Global Market Size for Other Consumables, By Region, 2014–2021 (USD Million)
Table 7 Global Market Size for Instruments, By Region, 2014–2021 (USD Million)
Table 8 Global Market Size for Software & Services, By Region, 2014–2021 (USD Million)
Table 9 Market Size, By Type of Test, 2014–2021 (USD Million)
Table 10 Market Size for Antibody Tests, By Type, 2014–2021 (USD Million)
Table 11 Market Size for Antibody Tests, By Region, 2014–2021 (USD Million)
Table 12 HIV-1 Screening Tests Market Size, By Type, 2014–2021 (USD Million)
Table 13 HIV-1 Screening Tests Market Size, By Region, 2014–2021 (USD Million)
Table 14 HIV-1 Screening Tests Market Size for Elisa, By Region, 2014–2021 (USD Million)
Table 15 HIV-1 Screening Tests Market Size for Rapid Tests, By Region, 2014–2021 (USD Million)
Table 16 HIV-1 Screening Tests Market Size for Home Access Dried Blood Spots, By Region, 2014–2021 (USD Million)
Table 17 HIV-1 Antibody Confirmatory Tests Market Size, By Type, 2014–2021 (USD Million)
Table 18 HIV-1 Antibody Confirmatory Tests Market Size, By Region, 2014–2021 (USD Million)
Table 19 HIV-1 Antibody Confirmatory Tests Market Size for Western Blot Tests, By Region, 2014–2021 (USD Million)
Table 20 HIV-1 Antibody Confirmatory Tests Market Size for Indirect IFA, By Region, 2014–2021 (USD Million)
Table 21 HIV-1 Antibody Confirmatory Tests Market Size for Line Immunoassays, By Region, 2014–2021 (USD Million)
Table 22 HIV-1 Antibody Confirmatory Tests Market Size for Radio-Immunoprecipitation Assays, By Region, 2014–2021 (USD Million)
Table 23 HIV-2 & Group O Diagnostic Tests Market Size, By Region, 2014–2021 (USD Million)
Table 24 Market Size for Viral Load Tests, By Region, 2014–2021 (USD Million)
Table 25 Market Size for CD4 Tests, By Region, 2014–2021 (USD Million)
Table 26 Market Size for Tests for Early Infant Diagnosis, By Region, 2014–2021 (USD Million)
Table 27 Market Size for Tests for Viral Identification, By Region, 2014–2021 (USD Million)
Table 28 Market Size, By End User, 2014–2021 (USD Million)
Table 29 Global Market Size for Diagnostic Laboratories, By Region, 2014–2021 (USD Million)
Table 30 Global Market Size for Hospitals, By Region, 2014–2021 (USD Million)
Table 31 Global Market Size for Blood Banks, By Region, 2014–2021 (USD Million)
Table 32 Global Market Size for Home Care Settings, By Region, 2014–2021 (USD Million)
Table 33 Global Market Size for Other End Users, By Region, 2014–2021 (USD Million
Table 34 Global Market Size, By Region, 2014–2021 (USD Million)
Table 35 North America: Market Size, By Country, 2014–2021 (USD Million)
Table 36 North America: Market Size, By Test Type, 2014–2021 (USD Million)
Table 37 North America: Market Size, By Product, 2014–2021 (USD Million)
Table 38 North America: Market Size, By End User, 2014–2021 (USD Million)
Table 39 U.S.: Market Size, By Test Type, 2014–2021 (USD Million)
Table 40 U.S.: Market Size, By Product, 2014–2021 (USD Million)
Table 41 U.S.: Market Size, By End User, 2014–2021 (USD Million)
Table 42 Canada: Market Size, By Test Type, 2014–2021 (USD Million)
Table 43 Canada: Market Size, By Product, 2014–2021 (USD Million)
Table 44 Canada: Market Size, By End User, 2014–2021 (USD Million)
Table 45 Number of HIV Tests in Europe, By Country, 2014
Table 46 Europe: Market Size, By Test Type, 2014–2021 (USD Million)
Table 47 Europe: Market Size, By Product, 2014–2021 (USD Million)
Table 48 Europe: Market Size, By End User, 2014–2021 (USD Million)
Table 49 Asia: Market Size, By Country, 2014–2021 (USD Million)
Table 50 Asia: Market Size, By Test Type, 2014–2021 (USD Million)
Table 51 Asia: Market Size, By Product, 2014–2021 (USD Million)
Table 52 Asia: Market Size, By End User, 2014–2021 (USD Million)
Table 53 China: Market Size, By Test Type, 2014–2021 (USD Million)
Table 54 China: Market Size, By Product, 2014–2021 (USD Million)
Table 55 China: Market Size, By End User, 2014–2021 (USD Million)
Table 56 Japan: Market Size, By Test Type, 2014–2021 (USD Million)
Table 57 Japan: Market Size, By Product, 2014–2021 (USD Million)
Table 58 Japan: Market Size, By End User, 2014–2021 (USD Million)
Table 59 India: Market Size, By Test Type, 2014–2021 (USD Million)
Table 60 India: Market Size, By Product, 2014–2021 (USD Million)
Table 61 India: Market Size, By End User, 2014–2021 (USD Million)
Table 62 RoA: Market Size, By Test Type, 2014–2021 (USD Million)
Table 63 RoA: HIV Diagnosis Market Size, By Product, 2014–2021 (USD Million)
Table 64 RoA: HIV Diagnosis Market Size, By End User, 2014–2021 (USD Million)
Table 65 RoW: HIV Diagnosis Market Size, By Test Type, 2014–2021 (USD Million)
Table 66 RoW: HIV Diagnosis Market Size, By Product, 2014–2021 (USD Million)
Table 67 RoW: HIV Diagnosis Market Size, By End User, 2014–2021 (USD Million)
Table 68 Growth Strategy Matrix, 2014–2016
Table 69 Product Launches, 2014–2016
Table 70 Agreements, Partnerships, & Collaborations, 2014–2016
Table 71 Expansions, 2014–2016
Table 72 Other Developments, 2014–2016


List of Figures (53 Figures)

Figure 1 Global HIV Diagnosis Market Segmentation
Figure 2 HIV Diagnosis Market: Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 HIV Diagnosis Market: Bottom-Up Approach
Figure 5 HIV Diagnosis Market: Top-Down Approach
Figure 6 HIV Diagnosis Market: Data Triangulation Methodology
Figure 7 Global HIV Diagnosis Market Size, By Product, 2016 vs 2021 (USD Million)
Figure 8 Global HIV Diagnosis Market Size, By Test Type, 2016 vs 2021 (USD Million)
Figure 9 Global HIV Diagnosis Market Size, By End User, 2016 vs 2021 (USD Million)
Figure 10 Geographical Snapshot of the HIV Diagnosis Market
Figure 11 Global HIV Diagnosis Market to Witness Moderate Growth During the Forecast Period
Figure 12 Antibody Tests Segment Commanded the Largest Share of the Global HIV Diagnosis Market in 2016
Figure 13 Asia Projected to Register the Highest CAGR During the Forecast Period
Figure 14 Asian Market Showcases Lucrative Growth Opportunities
Figure 15 HIV Diagnosis Market: Drivers, Restraints, Opportunities, and Trends
Figure 16 HIV Diagnosis Market Segmentation, By Product
Figure 17 Consumables Were the Largest Product Segment in the HIV Diagnosis Market in 2016
Figure 18 Assays and Kits & Reagents Were the Largest Product Segment in 2016
Figure 19 HIV Diagnosis Market Segmentation, By Test Type
Figure 20 Antibody Tests Were the Largest Test Segment in the HIV Diagnosis Market in 2016
Figure 21 HIV-1 Screening Tests Dominated the HIV Diagnosis Market for Antibody Tests in 2016
Figure 22 Elisa Was the Largest HIV-1 Screening Tests Segment in 2016
Figure 23 Western Blot Tests Were the Largest Segment in the HIV-1 Antibody Confirmatory Tests Market in 2016
Figure 24 Diagnostic Laboratories Commanded the Largest Market Share in 2016
Figure 25 Geographic Snapshot: Emerging Markets in Asia Offer Significant Growth Opportunities in the HIV Diagnosis Market
Figure 26 HIV Diagnosis Market in Asia to Register the Highest CAGR During Forecast Period
Figure 27 North America: HIV Diagnosis Market Snapshot
Figure 28 U.S. to Dominate the North American HIV Diagnosis Market During the Forecast Period
Figure 29 Antibody Tests Dominated the North American HIV Diagnosis Market, By Test Type, in 2016
Figure 30 Viral Load Tests Segment to Register the Highest CAGR in the U.S. HIV Diagnosis Market
Figure 31 Antibody Tests Form the Largest Segment in the Canadian HIV Diagnosis Market in 2016
Figure 32 Market for Viral Load Tests in Europe to Register the Highest Growth During the Forecast Period
Figure 33 China Dominated the Asian HIV Diagnosis Market in 2016
Figure 34 Asia: HIV Diagnosis Market Snapshot
Figure 35 Antibody Tests Accounted for the Largest Share of the Asian HIV Diagnosis Market in 2016
Figure 36 Antibody Tests Accounted for the Largest Share of the HIV Diagnosis Market in China in 2016
Figure 37 Antibody Tests Held the Largest Share of the Japanese HIV Diagnosis Market in 2016
Figure 38 Antibody Tests Accounted for the Largest Share of the Indian HIV Diagnosis Market in 2016
Figure 39 Antibody Tests Held the Largest Share of the RoA HIV Diagnosis Market in 2016
Figure 40 Antibody Tests Held the Largest Share of the RoW HIV Diagnosis Market in 2016
Figure 41 Product Launch Was the Key Strategy Adopted By Players in the HIV Diagnosis Market
Figure 42 HIV Diagnosis Market Share Analysis, By Key Player, 2015
Figure 43 Geographic Revenue Mix of the Top Six Market Players
Figure 44 Siemens AG: Company Snapshot (2016)
Figure 45 Roche Diagnostics: Company Snapshot (2015)
Figure 46 Abbott Laboratories: Company Snapshot (2015)
Figure 47 Danaher Corporation: Company Snapshot (2015)
Figure 48 Thermo-Fisher Scientific Inc.: Company Snapshot (2015)
Figure 49 Merck KGaA: Company Snapshot (2015)
Figure 50 Becton, Dickinson & Company.: Company Snapshot (2016)
Figure 51 Hologic Inc.: Company Snapshot (2016)
Figure 52 Alere Inc: Company Snapshot (2016)
Figure 53 Bio-Rad Laboratories: Company Snapshot (2015)

The HIV diagnosis market is projected to reach USD 3.88 Billion by 2021 from USD 2.35 Billion in 2016, at a CAGR of 10.5% from 2016 to 2021. Factors such as the growing worldwide prevalence of HIV/AIDS, increasing number of blood transfusions and blood donations, benefits offered by point-of-care instruments and kits, and increasing government initiatives are expected to drive the growth of the market worldwide.

This market is segmented based on product, test type, end user, and region. On the basis of product, the market is segmented into consumable (assays, kits, reagents, and other consumables), instruments, and software & services. In 2016, the consumables segment is expected to account for the largest share of the market due to the frequent and repetitive purchase of assays, kits, and reagents by laboratories, hospitals, and blood banks and also due to advancements in PoC testing.

On the basis of test type, the HIV diagnosis market is classified into antibody tests, viral load tests, CD4 count tests, tests for early infant diagnosis, and tests for viral identification. The antibody tests segment is further divided into HIV-1 screening tests, HIV-1 confirmatory tests, and HIV-2 and Group O diagnostic tests. The antibody tests segment is expected to account for the largest share of the market in 2016. This large share can be attributed to high prevalence of HIV/AIDS, increasing awareness about HIV/AIDS, increasing blood donations and advancements, and better offerings from PoC testing.

HIV Diagnosis Market

On the basis of end user, the HIV diagnosis market is divided into diagnostic laboratories, hospitals, blood banks, home care settings, and others (gene banks, cell banks, biotechnology and pharmaceutical companies, and academic research institutes). The diagnostic laboratories segment is expected to account for the largest share of market in 2016. This large share is mainly due to high investment and technological advancements of diagnostics laboratories and increasing awareness of HIV/AIDS

The global market is segmented into four major regions— North America, Europe, Asia, and the Rest of the World. In 2016, North America is expected to account for the largest share of the market, followed by Europe. North America will continue to dominate the market in the forecast period due to the high prevalence of HIV in this region, high healthcare expenditure, increasing blood donations, and rising awareness about HIV/AIDS. However, Asia is a promising market for HIV diagnostics, primarily due to increasing prevalence and incidence of HIV/AIDS, increasing number of blood donations, and increasing awareness among people regarding HIV/AIDS in this region.

Key players in the market include Siemens AG (Germany), Roche Diagnostics (Switzerland), Abbott Laboratories (U.S), Danaher Corporation (U.S.), Thermo-Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Becton, Dickinson and Company (U.S.), Hologic, Inc. (U.S.), Alere Inc. (U.S.), and Bio-Rad Laboratories (U.S.).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit https://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth In-Vitro Diagnostics Markets on KnowledgeStore
Request Demo